Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Nasopharyngeal Neoplasms
×
Docetaxel
×
Clear all
Filters
3
NCT02611960
2023-07-13
Keynote-122
Merck Sharp & Dohme LLC
Phase 3
Completed
233 enrolled
21 charts